Annual Report

Overview

The report describes Glenmark as a global pharmaceutical organisation with over 13,000 employees across 50 countries and a strategy focused on global generics, specialty and innovative products. It highlights a growing pipeline in oncology, respiratory and dermatology, alongside consolidated FY17 revenue of ₹ 91,856.81 mn from operations. Corporate Responsibility disclosures cover environmental, health and safety initiatives, community health, education, sustainable livelihoods, sports and employee wellbeing. The report also emphasizes Glenmark's innovation-led transformation and long-term sustainability agenda.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2016
Period: 1 April 2016 – 31 March 2017
Publication date: 11 May 2017
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services